Alliance Pharma Share Price | |
---|---|
Price | 32.00 |
Bid | 31.95 |
Ask | 32.00 |
Change | -1.10 (-3.32%) |
Volume | 4,439,000 |
Open | 34.50 |
High | 34.50 |
Low | 31.00 |
Prev. Close | 33.10 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 540.40m |
Market Capitalisation | £172.93m |
Market Size | 20,000 |
52 Week High | 72.60 |
52 Week High Date | 17-May-2023 |
52 Week Low | 31.00 |
52 Week Low Date | 07-May-2024 |
# Trades | 551 |
---|---|
Vol. Sold | 1,058,404 |
Sold Value | £336.73k |
Vol. Bought | 3,134,356 |
Bought Value | £1.02m |
PE Ratio | 188.23529 |
Earnings | 0.17 |
Dividend | 1.691 |
Yield | 5.284% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
07-May-24 | 17:07:38 | 32.00 | 7,500 | Unknown* | 31.95 | 32.00 | 2,400 | O Ordinary Was reported as OTC |
07-May-24 | 16:36:41 | 32.00 | 50,000 | Buy* | 31.95 | 32.00 | 16.00k | O Ordinary |
07-May-24 | 16:36:35 | 32.00 | 50,000 | Buy* | 31.95 | 32.00 | 16.00k | O Ordinary |
07-May-24 | 16:35:18 | 32.00 | 171,489 | Buy* | 31.95 | 32.00 | 54.88k | UT Uncrossing Trade |
07-May-24 | 16:29:55 | 31.994 | 31,218 | Buy* | 31.95 | 32.00 | 9,988 | O Ordinary |
07-May-24 | 16:29:54 | 32.00 | 296 | Buy* | 31.95 | 32.00 | 94.72 | A Automatic Execution |
07-May-24 | 16:29:50 | 32.00 | 663 | Buy* | 31.95 | 32.00 | 212.16 | A Automatic Execution |
07-May-24 | 16:29:49 | 32.00 | 114 | Buy* | 31.95 | 32.00 | 36.48 | A Automatic Execution |
07-May-24 | 16:29:49 | 32.00 | 2,505 | Sell* | 31.95 | 32.60 | 801.60 | A Automatic Execution |
07-May-24 | 16:29:49 | 32.00 | 1,242 | Buy* | 31.95 | 32.00 | 397.44 | A Automatic Execution |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
16-Oct-23 | 13-Oct-23 | Sell | Andrew Franklin held the position of CFO at the time of this trade.Andrew Franklin | 39.02 | GBX | 42,053 | 248,503 |
16-Oct-23 | 13-Oct-23 | Exercise of Option | Andrew Franklin held the position of CFO at the time of this trade.Andrew Franklin | 1.00 | GBX | 55,592 | 248,503 |
16-Oct-23 | 13-Oct-23 | Sell | Peter Butterfield held the position of CEO at the time of this trade.Peter Butterfield | 39.02 | GBX | 74,343 | 696,686 |
16-Oct-23 | 13-Oct-23 | Exercise of Option | Peter Butterfield held the position of CEO at the time of this trade.Peter Butterfield | 1.00 | GBX | 98,342 | 696,686 |
20-Jul-23 | 20-Jul-23 | Buy | Jo Le Couilliard held the position of Chairman at the time of this trade.Jo Le Couilliard | 48.80 | GBX | 40,957 | 40,957 |
We have a proven, consistent track record that enables us to invest for both organic growth and acquisitions